Warsaw, Poland

Piotr Cmoch

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 12.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Piotr Cmoch: Innovator in Pharmaceutical Chemistry

Introduction

Piotr Cmoch is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Cmoch's work focuses on compounds with pharmacological properties that can be utilized in medical treatments.

Latest Patents

Cmoch's latest patents include a protoescigenin derivative, which has been described as having pharmacological properties. This patent outlines a process for the preparation of this compound and its use as a medicament, especially for treating vascular disorders. Additionally, he has developed crystalline polymorphs of methanesulfonic acid addition salts of Imatinib. This invention details the synthesis of the crystalline α-form of Imatinib methanesulfonate and introduces a novel acid addition salt with specific pharmaceutical applications.

Career Highlights

Throughout his career, Piotr Cmoch has worked with esteemed organizations such as the Pharmaceutical Institute and the Medical University of Warsaw. His experience in these institutions has allowed him to advance his research and contribute to the development of new pharmaceutical compounds.

Collaborations

Cmoch has collaborated with notable colleagues, including Wojciech Szczepek and Dorota Samson-Lazinska. These partnerships have fostered a collaborative environment that enhances innovation in their respective fields.

Conclusion

Piotr Cmoch's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical field, particularly in the treatment of vascular disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…